Elisa Park, PharmD, Associate Director, Global Medical Information, Jazz Pharmaceuticals
Brian Scheckner, PharmD, BCPP, ISMPP CMPP, Senior Director, Medical Communications, Neuroscience Franchise, Jazz Pharmaceuticals
Mike Trabold, PharmD, Associate Director, Medical Science Liaisons, Jazz Pharmaceuticals

Moderator: Diane Sloan, PharmD, Executive Medical Director, Peloton Advantage

Medical Information and MSL groups are important strategic stakeholders in the publication planning process. Best practices allow an open forum for a bidirectional relationship between these groups and publication planning. Medical Information and MSL groups can provide valuable insights from the field (regional and/or global perspectives) to the publication team for consideration regarding unmet needs and frequent questions that can generate new analyses for subsequent publication development. In turn, publication content is then utilized by Medical Communication, Medical Information, and MSL groups to create content in various formats and to communicate with HCPs, payers, and other stakeholders.

Learning objectives:

• Recognize the value of establishing a bidirectional relationship between Medical Information/MSLs and publication planning groups
• Identify examples of insights provided by Medical Information/MSLs that can provide the basis for future publications
• Discuss how to establish a cohesive approach to optimize dissemination of consistent medical content